1 CMSS Physician Payment Sunshine Act FAQs These FAQs are intended as a resource for CMSS member organizations to create their own guidance document. The answers are based on the guidance that is publicly available as of August 23, This is a new reporting program, and many of the questions are still being clarified. Societies may take different positions on some of these questions. Readers of this document are encouraged to consult their attorneys, funding organizations, and CMS for interpretations of the Physician Payment Sunshine Act (PPSA) and the regulations operationalizing it. The information in this document is not legal advice. I. To Whom Does Sunshine Reporting Apply? 1) Why should I care about the Physician Payment Sunshine Act (PPSA), what CMS now terms its Open Payments Program? Section 6002 of the Affordable Care Act requires manufacturers of covered drugs, devices, biologicals, and medical supplies operating in the United States to report to the Centers for Medicare and Medicaid Services (CMS) any payments or transfers of value they make to teaching hospitals or physicians 1. CMS will collect the data annually, requiring data to be submitted by manufacturers to CMS by March 31, CMS will then aggregate the data and publish it on a public website. As of August 1, 2013, manufacturers are required to collect data on payments or transfers of value they make. 2) Are any physicians excluded from being covered by the Physician Payment Sunshine Act? Only medical residents are excluded from the Sunshine Act s application. The final rule exempted payments to medical residents from the reporting requirements solely due to operational and data accuracy concerns regarding aggregation of payments or other transfers of value to residents, many of whom have neither a National Provider Identifier (NPI) nor a State professional license. CMS has said because these same concerns do not generally apply to physicians in Fellowship training, payments to Fellows are not exempt from the reporting requirements. 1 CMS defines a physician under the Physician Payment Sunshine Act using its 1861(r) Medicare definition. Therefore, a physician is a Doctor of Medicine, Doctor of Osteopathy, Doctor of Dentistry, Doctor of Dental Surgery, Doctor of Podiatry, Doctor of Optometry, or a Doctor of Chiropractic Medicine.
2 3) The federal Sunshine Act also mandates pharmaceutical and medical device manufacturers, as well as GPOs, report payments or transfers of value made to teaching hospitals. How can I find a list of teaching hospitals? The following link provides a list of hospitals CMS defines as teaching hospitals, thus eligible for GME funding, that can be publicly reported if they accept Sunshine Act reportable payments or transfers of value from applicable manufacturers: Transparency-Program/Downloads/Teaching-Hospital-List-for-2013-Open-Payments- Program-Cycle pdf.pdf. 4) What does CMS mean when it says Group Purchasing Organizations (GPOs) 2, in addition to physicians and teaching hospitals, must refer any payments or transfers of value they receive from pharmaceutical or medical device manufacturers? CMS means GPOs must report information on ownership and investment interests held by physicians and their immediate family members, as well as any payments or other transfers of value made to physician owners or investors if they held ownership or an investment interest in the GPO at any point during the reporting year. 5) What is the intent behind CMS s Open Payments Program? CMS wants to shed light on relationships between industry and physicians and industry and teaching hospitals. II. What Must Be Reported? 1) Payments or Transfers of Value Exceeding $10 In general, payments or transfers of value exceeding $10 must be reported. If a PPSA exclusion 3 applies, it can supersede the $10 or greater reporting rule and result in manufacturer reporting not being mandated. 2 A GPO is defined as an entity that is created to leverage the purchasing power of a group of businesses to obtain discounts from vendors based on the collective buying power of the GPO members. 3 The following are excluded from being reported under the PPSA: certified and accredited CME, buffet meals or snacks at large-scale events, product samples not intended for sale but for patient use, in-kind items used for the provision of charity care, discounts, the loan of a medical device for the short-term, transfers of value and payments made to a physician in return for non-physician services from the physician (e.g., physician who is also a lawyer
3 2) Non-Accredited/Non-Certified Continuing Medical Education (CME)- The PPSA creates blanket reporting rules for transfers or payments of value arising from being the faculty speaker OR a physician attendee at a non-accredited/non-certified CME event. All tuition and educational fees arising from non-accredited/non-certified CME, as well as any lodging, meals, speaker fee, or travel funds the speaker physician receives must be reported 3) Educational Materials Given to the Physician Not Meant to be of Benefit to the Patient or Not Used With the Patient- The PPSA requires reporting of medical textbooks (e.g., reference manuals, the DSM-5, casebooks, guidebooks and other similar materials) and journal reprints provided by an applicable pharmaceutical or medical device manufacturer or GPO to a physician. 4) Meals at Meetings When the Physician is Identifiable to the Manufacturer In instances in which the value of a meal funded by an applicable manufacturer or GPO exceeds $10, and the persons partaking of the meal are readily identifiable at the time the meal is being provided to the applicable manufacturer or GPO, the meal is reportable. Only persons partaking of the meal are reportable. For example, a physician who bring his/her lunch to the meeting, while every other physician consumes the lunch provided by the manufacturer, will not be reported. Note: There is a reporting exception for instances in which a buffet is served to physicians as part of a large-scale meeting. 5) Indirect Transfers Made to a Third Party When the Manufacturer Requires, Instructs, or Directs the Payment or Transfer of Value be Provided to A Physician Indirect payments or transfers of value that an applicable manufacturer or GPO makes to a third party, such as a physician organization, are reportable when the manufacturer requires, instructs, or directs the payment or transfer of value be provided to a specific physician or intended generally for physicians. It does not necessarily matter that the manufacturer does not know in advance of the payment or transfer the name of the physician or physicians benefiting from the indirect transfer. If the manufacturer is requiring, instructing, or directing the transfer be made providing legal services to an applicable manufacturer or GPO), items or services provided under a contractual warranty, a dividend or other profit distribution, or ownership or investment interest in a publicly traded security and mutual fund.
4 to a physician or group of physicians, and the manufacturer could become aware of the identity of physicians to whom a transfer has been made within the period of time specified by the rule operationalizing the PPSA (which is during the reporting year or by the end of the second quarter of the following reporting year ), the manufacturer must report the names of the physicians benefiting from the payment or transfer of value to CMS. Note: CMS establishes an independence test when assessing whether an indirect transfer must be reported. If the manufacturer retains the independence in determining whether a physician or group of physicians benefits from the payment, CMS mandates the indirect transfer be reported. 6) Payments or Transfers of Value for Research The physician serving as the principal investigator gets reported, as well as the institution performing the research. Research payments will be displayed by CMS in a separate section of the Open Payments public website. III. Administration of Sunshine 1) What are the key dates for the Physician Payment Sunshine Act s Open Payments reporting? Applicable manufacturers and GPOs must begin to collect the required Sunshine data by August 1, 2013 and report the data collected through December 31, 2013 to CMS by March 31, By September 30, 2014, CMS will publish the reported data on a publicly available website. 2) If I receive a payment or transfer of value from a pharmaceutical or medical device manufacturer or GPO, can the manufacturer require me to provide my NPI number? Yes. One of the main requirements under the Sunshine reporting provisions is that applicable manufacturers and GPOs include in its report to CMS a physician's name, address, NPI number, and other identifying information all based on information in the NPPS database. To see the template of information manufacturers must use for reporting payments or transfers of value made to physicians in a non-research context, go to Guidance/Legislation/National-Physician-Payment-Transparency-Program/Downloads/General- Payments-OMB-No pdf. To see the template of information manufacturers must use for reporting payments or transfers of value made to physicians for furthering research, go to
5 and-guidance/legislation/national-physician-payment-transparency- Program/Downloads/Research-Payments-Submission-File-Specifications.pdf. To see the template GPOs must use for reporting payments or transfers of value made to physicians who have ownership or investment interests in GPOs, go to Transparency-Program/Downloads/Physician-Ownership-Submission-File-Specifications.pdf. 3) How will I track whether or not my name is mentioned in a manufacturer s report to CMS? CMS is creating a portal as part of its Open Payments Program website, where covered recipients like physicians and teaching hospitals can register to see whether their name is included in a manufacturer s submitted report. Being registered with the Open Payments portal allows physicians and teaching hospitals to receive timely notification on when they ve been mentioned in a manufacturer s report. It also provides a forum in which they can dispute the information included within the manufacturer s report. Physicians can register with the Open Payments physician portal in January ) How can I correct an error that appears in an applicable manufacturer s report? Once the manufacturer has submitted data listing the physicians names to CMS, CMS must give the physicians 45 days to review and work with the manufacturer, or applicable Group Purchasing Organization (GPO), to correct the information. After the 45 days have passed, the manufacturer or applicable GPO will have an additional 15 days to submit correction based on any disputes identified by physicians and physician owners/investors. The review and correction period starts at least 60 days before the information is made public. During the review and correction period, physicians and physician owners/investors can dispute information about them they do not think is correct. If data is disputed, CMS will notify the applicable manufacturer or applicable GPO that some of their data has been disputed. However, CMS will not mediate the dispute directly. 5) What happens when a reporting dispute is resolved? Once the dispute is resolved, the applicable manufacturer or GPO must send CMS a revised report for the correct data and re-attest that it is correct. Though the review and correction system will be open year-round, only the data corrections noted during the 45-day review and correction period, and subsequent 15-day dispute resolution period, will be updated before publication. CMS will update data from the current and previous year at least once annually, in addition to the initial data publication that followed data submission.
6 6) What happens when a dispute cannot be resolved? CMS will publish the data most recently submitted by the applicable manufacturer or GPO on its website, and it will mark the data as disputed. IV. What Is Excluded from PPSA Reporting? 1) Payments or Transfers of Value Less than $10 CMS has said that a transfer of anything for which the value is less than $10 need not be reported. However, if over the course of a calendar year the aggregate amount transferred to, requested by, or designated on behalf of the physician or teaching hospital by the applicable manufacturer or GPO exceeds $100, the payment or transfer of value is reportable. Note: Payments or transfers of value for less than $10 provided at large-scale conferences and similar events, as well as events open to the public, do not need to be reported nor included for the purposes of the aggregate threshold, even if the aggregate total for a covered recipient exceeds the aggregate threshold ($100 in CY 2013). 2) Speaker Physician s Fees, Travel, Meals, and Lodging Arising from an Accredited/Certified CME Event in instances in which all of the following criteria are met: (1) the CME program meets the accreditation or certification requirements and standards of the Accreditation Council for Continuing Medical Education, the American Academy of Family Physicians, the American Dental Association s Continuing Education Recognition Program, the American Medical Association, or the American Osteopathic Association, (2) the applicable manufacturer does not select or suggest the covered recipient speaker nor does it provide the third party vendor with distinct, identifiable individuals to be considered as speakers for the accredited or certified continuing education programs; AND (3) the applicable manufacturer does not directly pay the covered recipient speaker. 3) Attendee Physician s Educational and Tuition Fees Arising from an Accredited/Certified CME in instances in which all of the following criteria are met: (1) the CME program meets the accreditation or certification requirements and standards of the Accreditation Council for Continuing Medical Education, the American Academy of Family Physicians, the American Dental Association s Continuing Education Recognition Program, the American Medical Association, or the American Osteopathic Association,
7 (2) the applicable manufacturer does not select or suggest the covered recipient speaker nor does it provide the third party vendor with distinct, identifiable individuals to be considered as speakers for the accredited or certified continuing education programs; AND (3) the applicable manufacturer does not directly pay the covered recipient speaker. Note: Only the Speaker Physician at an accredited CME event qualifies for not reporting the meal, lodging, and travel fees which arise from his/her serving as faculty at an accredited CME. The Attendee Physician only gets a reporting exclusion for his/her tuition and educational fees arising from attending an accredited CME event. So any lodging, meals, or travel fees provided by the applicable manufacturer or GPO to the accredited CME attendee physician must be reported. 4) Educational Materials or Items Directly Benefiting Patients or Intended for Patient Use To claim this reporting exclusion, the educational materials being used must directly benefit the patient and/or be of use to the patient while he/she is seeing the physician. A human skeletal set would be an example of an item that could qualify for this reporting exclusion. 5) Buffet Meals, Snacks, Soft Drinks, or Coffee Generally Available to All Participants of Large-Scale Conferences and Similar Large-Scale Events CMS excludes buffet meals, snacks, soft drinks, and coffee provided by manufacturers from being reported in instances in which these items are made generally available to all participants of a large-scale conference or similar large-scale event. 6) Indirect Payments or Other Transfers of Value where the Applicable Manufacturer is Unaware of the Identity of the Covered Recipient CMS defines an applicable manufacturer as being unaware of the identity of a covered recipient if the manufacturer does not know (i.e., actual knowledge, acts in deliberate ignorance of the truth, or acts in reckless disregard of the truth) the identity of the covered recipient during the reporting year or by the end of the second quarter of the following reporting year. Note: With respect to indirect transfers made by a manufacturer to a physician society and earmarked for the purpose of funding awards or grants for physicians, CMS expressly states in the rules operationalizing PPSA that these awards or grants would constitute indirect payments to covered recipients and would be subject to reporting requirements. In this instance, CMS does not indicate there is a reporting exclusion where the manufacturer does not know the specific identity of the physician or physicians benefiting from the awards or grants it has funded. It simply concludes awards or grants provided generally to physicians constitute indirect
8 payments that must be reported. We believe manufacturers are likely to be cautious and report all awards and/or grants they indirectly fund for physicians through physician societies. Additional PPSA reporting exclusions include: In-kind items used for the provision of charity care Discounts or rebates Loan of a medical device for the short-term Transfers of value and payments made to a physician in return for non-physician services from the physician (e.g., physician who is also a lawyer providing legal services to an applicable manufacturer or GPO) Items or services provided under a contractual warranty A dividend or other profit distribution, or ownership or investment interest in a publicly traded security and mutual fund. V. General PPSA Inquiries 1) What are the definitions or financial limits defining reportable gifts of value? Who decides what the value is? There are no financial limits on reportable gifts of value. Those gifts that are under the $10 limit as well as small items provided at conferences are not reportable. However, if a manufacturer provides a number of these de minimus items that are less than $10 but amount to $100 annually, then those items are reportable. 2) Will physicians/members be reported as having received a gift of value simply by being prorated as part of a larger group that collectively received such a gift, or does it only apply to individually given and received gifts of value? Only those physicians who received the value of the gift will be reported, but all members of a group practice that receive the benefit of the gift will be reported for the value they received. So, if a pharmaceutical representative provides a dinner for a group practice, all members of the group who attend the dinner will be reported for the value of their individual dinner. 3) If an individual member is identified or reported by industry as having received something of commercial value (pens, pads, bags, lunch, etc.), what will be required of them?
9 Physicians have no legal obligations under the law. However, it is in their best interests to track transfers of value in order to respond quickly to inaccurate reports within the 60 day review and dispute period. 4) What, if any, unintended consequences of the PPSA do medical societies anticipate? Media, patients, and members of the public may scrutinize physician-manufacturer relationships more closely, possibly resulting in questions or feedback for the physician. Some payments or transfers of value may be disclosed on the Open Payments site that are not required to be disclosed under the societies own policies. The PPSA could lead to scrutiny and greater enforcement of state consumer protection laws which may require physician disclosure of financial relationships prior to rendering treatment to patients. In addition, a society s Key Leaders under the CMSS Code for Interactions with Health Care Companies may receive a transfer of value that is reportable to the Open Payments website while still being allowable under the CMSS Code. For instance, attendance at a company-sponsored dinner or payments to an academic department for a research grant in which the Key Leader is a principal investigator would be disclosed but not restricted under the society s policies and the CMSS Code, and would be reportable to the Open Payments website. 5) If in my capacity as President of my incorporated state medical society I sign a contract with a pharmaceutical or medical device manufacturer for the manufacturer to have an exhibit booth at the medical society s conference, can the transfer of funds for which I have signed be attributed to me and be reportable to CMS under the PPSA? No. A physician who signs a contract in his/her capacity as an executive or officer of an incorporated medical society or other organization is not personally receiving a transfer of value from the manufacturer. This individual should not be considered a covered recipient under the PPSA in the context of performing his/her incorporated medical society/organization officer duties. VI. How does PPSA Affect Physician Societies? 1) Will the PPSA be more likely to impact individual members or physician societies? PPSA will affect both physician members and their professional societies. It will affect physician members directly because they will be subject to being reported for covered payments from manufacturers. Societies will be indirectly affected because manufacturers that sponsor society functions will put pressure on the societies to provide
10 them with names of physician members who must be reported as a result of such sponsorships. 2) Can member physicians be unaware of having been reported as receiving a gift of value? How will members know if a commercial entity reports a gift of value to them, of which they do not have actual knowledge? Yes, CMS will provide a general notice to physicians registered through its Open Payments website portal that the manufacturer data is available for review. However, if a physician does not sign up on the CMS website and/or regularly check the OPEN PAYMENTS website, then he or she will not receive such notification and may miss the opportunity to review and dispute manufacturer reports. Note that this only a general notification it will not notify specific physicians when their names are reported by manufacturers. 3) Are there any actions a physician society can take on the collective behalf of its members to assist in compliance or education about their role and rights under the PPSA? Physician societies should educate their members about internal tracking, signing up for CMS notifications, and raising general awareness of the Sunshine Act and its potential implications. Physician societies should also notify their members when they provide those members names to particular manufacturers in connection with a reportable transfer of value. 4) Is the federal Sunshine Act the only law under which physicians may be reported by pharmaceutical or medical device manufacturers and/or GPOs for receiving payments or transfers of value from them? Some states enacted their own Sunshine reporting laws prior to the implementation of Section 6002 of the federal Affordable Care Act, known as the Physician Payment Sunshine Act. The rule operationalizing the federal Physician Payment Sunshine Act clarifies that any provisions of existing state Sunshine reporting laws which directly conflict with manufacturers being able to fulfill the provisions of the federal Sunshine Act are preempted, thus superseded, by the applicable provision of the federal Sunshine Act.
11 To see whether your state has its own Sunshine physician payment law, go to the AMA s chart of state Sunshine laws at https://www.ama-assn.org/resources/doc/washington/statesunshine-laws-chart.pdf. Additionally, states have consumer protection laws which may require physician disclosure to patients of certain relationships with manufacturers prior to rendering treatment.
Brief Summary of the National Physician Payment Transparency Program: Open Payments Physician Payment Sunshine Act (Prepared by the Department of Health Policy and Regulatory Affairs, February 26, 2013)
Open Payments (Physician Payments Sunshine Act) Why Open Payments is Important to You Section 6002 of the Affordable Care Act requires the establishment of a transparency program, now known as Open Payments.
August 22, 2014 The Honorable Marilyn Tavenner Administrator Centers for Medicare & Medicaid Services 7500 Security Blvd. Baltimore, MD 21244 Dear Administrator Tavenner: The American Association of Colleges
CMS Publishes Final Sunshine Act Rule; Data Collection to Begin on August 1, 2013 By Thomas S. Crane, Brian P. Dunphy, Kimberly J. Gold, Karen S. Lovitch, James N. Sasso, and Kate F. Stewart The long-awaited
CME Updates Douglas W. Hanto, M.D., PhD Associate Dean for Continuing Medical Education Professor of Surgery Vicki Tegethoff, RN, MHA Director of CME cme.wustl.edu Purpose of this Presentation This presentation
group practice journal P U B L I C A T I O N O F T H E A M E R I C A N M E D I C A L G R O U P A S S O C I A T I O N Reprinted from Electronic Health Record Offers: What s a Doctor to Do? BY ELLEN F. KESSLER,
Introduction GUIDE TO VERMONT S PRESCRIBED PRODUCTS LAW FOR FY10 DISCLOSURES Published by the Vermont Office of the Attorney General 11/5/2009 Effective July 1, 2009, Vermont law bans certain gifts and
MA Healthcare Reform Legislation: Assessment of Massachusetts Department of Public Health Regulations Pri-Med Institute Marissa Seligman, PharmD email@example.com DISCLAIMER: For informational
Shedding Light on Marketing Practices & Physician Industry Financial Relationships Federal Stark Law Implications & The Sunshine Act The Health Law Partners, P.C. www.thehlp.com (248) 996 8510 Adrienne
Page 1 of 9 BCM Policies and Procedures Table of Contents Return to Section 02.9.10 - Human Resources: Conflict of Interest Date: 10/17/2001 Conflict Of Interest - College Personnel Last Update: 04/09/2009
Shedding Some Fair Market Value Light on the Sunshine Act Sponsored by the Life Science (LS) Practice Group February 3, 2011 12:00 pm EST Presenters: Celine Cely Valuation Consultant Sinaiko Healthcare
May 14, 2009 BY ELECTRONIC MAIL The Honorable Charles E. Grassley Ranking Member, Committee on Finance United States Senate 219 Dirksen Senate Office Building Washington, DC 20510-6200 Health_Reform@finance-dem.senate.gov
University of Cincinnati College of Medicine Policy Policy and Guidelines for Industry Relationships Policy and Guidelines for Industry Relationships FAQ Date Updated Page 5/14/2008 2 -- 8 NB: The Institute
Table of Contents General Grant Questions What type of grants/giving does Merz support? What are some benefits of online application? Who can apply for a grant? How long does the application process take?
ADOPTION OF MARKETING EXPENSE BUDGET AND GIFT POLICY BY: JEFFREY S. BAIRD, ESQ. BROWN & FORTUNATO, P.C. HEALTH CARE GROUP P.O. BOX 9418 AMARILLO, TX 79105 (806) 345-6320 (806) 345-6363 - FAX JBAIRD@BF-LAW.COM
PAGE 1 OF 5 I. PURPOSE The purpose of this Policy is to fulfill the requirements of Section 6032 of the Deficit Reduction Act of 2005 by providing to Creighton University employees and employees of contractors
MEDICAL EDUCATION GRANTS: FREQUENTLY ASKED QUESTIONS WHICH GUIDELINES AND/OR REGULATIONS DOES THE ALLERGAN MEDICAL EDUCATION DEPARTMENT ADHERE TO? Allergan s grant approval process is in full accordance
This document is scheduled to be published in the Federal Register on 02/08/2013 and available online at http://federalregister.gov/a/2013-02572, and on FDsys.gov 1 DEPARTMENT OF HEALTH AND HUMAN SERVICES
Finally... maybe? The Long Awaited 340B Mega Guidance Georgia Healthcare Financial Management Association October 2015 Disclaimer This webinar assumes the participant is familiar with the basic operations
Introduction GUIDE TO VERMONT S PHARMACEUTICAL MARKETING DISCLOSURE LAW FOR FY09 DISCLOSURES Published by the Vermont Office of the Attorney General 10/09/09 Effective July 1, 2009, Vermont law bans certain
Medicare Coverage Gap Discount Program (Filling the Donut Hole) Summary: Requires drug manufacturers to provide a 50 percent discount to Part D beneficiaries for brand name drugs and biologics purchased
I. Goal and Scope CODE OF ETHICS ON INTERACTIONS WITH HEALTH CARE PROFESSIONALS Effective March 23, 2015 Symmetry Surgical Inc. ( Symmetry ) has an obligation to facilitate ethical interactions between
A. General. CONDUCTING BUSINESS WITH HEALTH CARE PROFESSIONALS. This policy governs the interactions between Company personnel and health care professionals. The term health care professional means any
SAMPLE INSURANCE BROKER COMPENSATION DISCLOSURE (For Use by Insurance Brokers in Providing Disclosures To Retirement Plan Clients of Indirect Compensation Expected To Be Received From John Hancock Life
ISR whitepaper The Sunshine Act and Clinical Research Views from Principal Investigators and Primary Cary Physicians Info@ISRreports.com 2013 Industry Standard Research www.isrreports.com Finally! After
Rules Governing the Forgivable Education Loans for Service Program A Program of the State of North Carolina Administered by the State Education Assistance Authority 10 T.W. Alexander Drive P. O. Box 13663
PhRMA Code on Interactions with Healthcare Professionals Preamble The Pharmaceutical Research and Manufacturers of America (PhRA4.A) represents research-basedpharmaceutical and biotechnology companies.
HIPAA Business Associate Agreement Sample Notice Disclaimer: Template Business Associate Agreement (45 C.F.R. 164.308) The information provided in this document does not constitute, and is no substitute
European Board for Accreditation in Hematology Standards & Guidelines Standards 1 Only CME activities that exclusively benefit hematologists and their patients are eligible for accreditation. 2 Only academic
TERMS AND CONDITIONS OF USE PLEASE READ THESE TERMS AND CONDITIONS OF USE CAREFULLY. THESE TERMS AND CONDITIONS OF USE MAY HAVE CHANGED SINCE YOUR LAST VISIT TO THIS WEB SITE. BY USING THIS WEB SITE, YOU
Eucomed M e d i c a l T e c h n o l o g y Code of Ethical Business Practice Eucomed Guidelines on Interactions with Healthcare Professionals Amended September 2008 - Board approved, 11 September 2008 The
DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services NEW products from the Medicare Learning Network (MLN) Transitional Care Management Services, Fact Sheet, ICN 908682, Downloadable
The Ohio State University Medical Center Vendor Interaction Policy Approved OSUMC Executive Cabinet, March 12, 2009 Policy effective July 1, 2009 Purpose All healthcare professionals and institutions have
University of Washington School of Medicine Effective: 02/08/2007; Revised: 7/2009, 8/08/2013 Graduate Medical Education Page 1 of 7 Resident/Fellow Moonlighting Policy Scope: This policy applies to Residents
SERVICES AGREEMENT THIS AGREEMENT is between, with offices at (hereinafter referred to as COMPANY ), and the University of Delaware, a nonprofit institution of postsecondary education chartered under the
I. SCOPE: Law Department Policy No. L-4 Page: 1 of 10 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity
Compliance Tip Sheet National Hospice and Palliative Care Organization www.nhpco.org/regulatory HHS Issues New HITECH/HIPAA Rule: Implications for Hospice Providers Hospice Provider Compliance To Do List
Conflict of Interest Policy I. Purpose This policy provides guidance regarding conflicts of interest and is intended to supplement, but not replace, state and federal laws governing conflicts of interest
Policy for Managing Private Healthcare Industry* (PHCI) Interactions at the UNM HSC Clinical Care and Educational Missions** Approved by the SOM Committee of Chairs January 23, 2008. Approved by the COP
I. SCOPE: Law Department Policy No. L-1 Page: 1 of 6 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity
Part 2A of Form ADV: F I R M B R O C H U R E Dated: 03/24/2015 Contact Information: Bob Pfeifer, Chief Compliance Officer Post Office Box 2509 San Antonio, TX 78299 2509 Phone Number: (210) 220 5070 Fax
Referral Agency and Packaging Agency Agreement Please read this agreement carefully. In signing this agreement, you acknowledge that you have read, understood and agree to be bound by each and every provision
D. Public Health Service (PHS) Agency-Supported Rules Idaho State University has developed a conflict of interest (CoI) policy that applies to all ISU employees. Additionally, the following policies and
Conflicts of Interest and the Age of Transparency Tammy Capretta, RN, MPH, CHC Asst. Vice President, Healthcare Compliance Daniel Shapiro, JD Director, Research Compliance COI-Related Disclosure Requirements
Vendor Relationships/Gifts FAQs Integrity Office Mail code L106 RI 3181 S.W. Sam Jackson Park Road Portland, Oregon 97239-3098 tel: 503 494-8849 fax: 503 346-6808 Frequently Asked Questions General 4 1.
Big Data: Navigating the Recent and Pending Releases of CMS Data Sets Bernard J. Ford, Navigant Consulting, Inc. Benjamin Koplin, Fulbright & Jaworski LLP (Norton Rose Fulbright) Lesley Reynolds, Fulbright
State Marketing Law Compliance: Implications of Federal Sunshine Act Preemption Ronald L. Wisor, Partner February 19, 2013 Health / United States Agenda Types of state marketing laws State-specific requirements
Institutional for Private Education Loans Maryville University of Saint Louis November 30, 2009 1 - Introduction The Higher Education Act requires institutions to develop and implement a code of conduct
1. Please describe the key components of the GPO s written code of business ethics and conduct. (Please provide a copy and describe any changes since the last submission.) Please assure your response includes:
SUBJECT Policy and Procedures: Identification and Resolution of Conflicts of Interest for CME Activities EFFECTIVE DATE June 21, 2012 REVISED October 4, 2012 Harvard Medical School Department of Continuing
Connecting America for Better Health Medicare Electronic Health Record Incentive Payments for Eligible Professionals The American Recovery and Reinvestment Act (Recovery Act) of 2009 provides for incentive
1 Chicago Medical Society s Policies for Commercial Support, Faculty Members, Authors, Planners, Course Directors, Committee and Staff Members, Reviewers, and Joint Providers: Honoraria: Only faculty members
Medicare Electronic Health Record Incentive Program The American Recovery and Reinvestment Act (Recovery Act) of 2009 provides for incentive payments for Medicare eligible professionals (EPs) who are meaningful
UPDATED OIG Guidelines for Evaluating State False Claims Acts Note: These guidelines are effective March 15, 2013, and replace the guidelines effective on August 21, 2006, found at 71 FR 48552. UPDATED
Data Breach, Electronic Health Records and Healthcare Reform (This presentation is for informational purposes only and it is not intended, and should not be relied upon, as legal advice.) Overview of HIPAA
Conflict of Interest Policy PURPOSE: The JASA Corporation and its affiliates and subsidiaries (each, individually a JASA Entity and collectively JASA Entities ) aim to ensure that all of its business practices
2011 Instructions for Schedule L (Form 990 or 990-EZ) Transactions With Interested Persons Department of the Treasury Internal Revenue Service Section references are to the Internal do so, it must file
Industry Sponsored Satellite Symposia Information and Application Dear ACOOG Annual Conference Exhibitor: Thank you for your interest in planning an Industry Supported Satellite Symposium in conjunction
Medicare Enrollment By Dr. Ron Short, DC, MCS-P Why Enroll in Medicare?This is one of the most common questions that I am asked. You are required by law to to bill Medicare for covered services rendered
I. SCOPE: Law Department Policy No. L-6 Page: 1 of 7 This policy applies to (1) Tenet Healthcare Corporation and its wholly-owned subsidiaries and affiliates (each, an Affiliate ); (2) any other entity
Contact Information State Business Entities Department: Florida Department of State Division of Corporations Mailing Address: PO Box 6327 Tallahassee, FL 32314-6327 Physical Address: Clifton Building 2661
Texas Tech University Health Sciences Center Request for Qualifications West Texas Health Information Technology Regional Extension Center A Program of the F. Marie Hall Institute for Rural and Community
CONFLICT OF INTEREST POLICY and STATEMENT OF FIDUCIARY RESPONSIBILITY Original: Approved by Foundation Board - 9.8.2005 Revision #1: Approved by Foundation Board - 6.30.2014 CONFLICT OF INTEREST POLICY
STATE OF NEVADA DEPARTMENT OF HEALTH AND HUMAN SERVICES DIVISION OF HEALTH CARE FINANCING AND POLICY MICHAEL J. WILLDEN Director BRIAN SANDOVAL Governor CHARLES DUARTE Administrator Medicaid Electronic
Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved. Contact Information Debjit Ghosh Life Sciences Practices
Conflict of Interest Disclosure System Frequently Asked Questions CONTENTS: (click the title below to move to the section within the document) System Access FAQs Discloser FAQs Approver FAQs Policy General
ASHP Regulations on Accreditation of Pharmacy Technician Training Programs I. Introduction Pharmacists have long recognized the need for a corps of technically trained personnel in the profession of pharmacy.
MH Policy and Procedure Document Number: MH-COMPLY-001 Document Owner: Corporate Compliance Officer Date Last Author: Corporate Compliance Officer General Description Purpose: To establish written guidelines
Adopting an EHR & Meaningful Use Learn how to qualify for the EHR Incentive Program The materials in this presentation, or prepared as part of this presentation, are provided for informational purposes
Standards for Programs Designated for AAPA Category 1 CME Credit CME Mission Statement The mission of the AAPA s CME Review Panel is to review and approve appropriate clinical and professional educational
Contact Information State Business Entities Department: Georgia Secretary of State Corporations Division Mailing Address: Floyd West Tower Suite 313 2 Martin Luther King Jr. Drive S.E. Atlanta, Georgia
Nebraska Workers Compensation Court Information Sheet: Rights & Obligations under the Nebraska Workers Compensation Law NEBRASKA WORKERS COMPENSATION COURT OFFICIAL SEAL What is workers compensation? Workers
INVESTMENT ADVISORY AGREEMENT This Investment Advisory Agreement sets forth the terms upon which Client engages Grossman Financial Management as a financial and investment advisor. Agreement The undersigned
FirstCarolinaCare Insurance Company Business Associate Agreement THIS BUSINESS ASSOCIATE AGREEMENT ("Agreement"), is made and entered into as of, 20 (the "Effective Date") between FirstCarolinaCare Insurance
Resident Job Search Guide Resources for a Successful Position Search and Interview Acknowledgements: thank you to Joseph Vitale, M.Ed., Ed.S., J.D., Director of the Cleveland Clinic Office of Physician
INDIANA UNIVERSITY POLICY ON FINANCIAL CONFLICTS OF INTEREST IN RESEARCH (Approved: UFC 9/12/00, 3/9/04, 4/27/04, 11/24/09; Trustees 9/15/00, 3/3/06) The trustees, administration, faculty, and staff of
The Appeals Process For Medical Billing Steven M. Verno Professor, Medical Coding and Billing What is an Appeal? An appeal is a legal process where you are asking the insurance company to review it s adverse